Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 22.15 USD -2.08% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Kiniksa Pharmaceuticals Ltd?
Write Note

Kiniksa Pharmaceuticals Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kiniksa Pharmaceuticals Ltd
Interest Income Expense Peer Comparison

Comparables:

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Interest Income Expense
$9.5m
CAGR 3-Years
441%
CAGR 5-Years
7%
CAGR 10-Years
N/A

See Also

What is Kiniksa Pharmaceuticals Ltd's Interest Income Expense?
Interest Income Expense
9.5m USD

Based on the financial report for Sep 30, 2024, Kiniksa Pharmaceuticals Ltd's Interest Income Expense amounts to 9.5m USD.

What is Kiniksa Pharmaceuticals Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
7%

Over the last year, the Interest Income Expense growth was 36%. The average annual Interest Income Expense growth rates for Kiniksa Pharmaceuticals Ltd have been 441% over the past three years , 7% over the past five years .

Back to Top